FY2025 EPS Estimates for Core Scientific Reduced by Analyst

Core Scientific, Inc. (NASDAQ:CORZ) – Equities research analysts at Roth Capital decreased their FY2025 earnings per share estimates for shares of Core Scientific in a note issued to investors on Tuesday, January 7th. Roth Capital analyst D. Aftahi now expects that the company will earn ($0.30) per share for the year, down from their prior estimate of ($0.29). Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at $0.33 EPS.

Several other research firms have also commented on CORZ. Canaccord Genuity Group assumed coverage on shares of Core Scientific in a research report on Monday, September 23rd. They issued a “buy” rating and a $16.00 price target on the stock. HC Wainwright increased their target price on Core Scientific from $15.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Roth Mkm initiated coverage on Core Scientific in a research report on Friday, November 15th. They set a “buy” rating and a $25.50 price target for the company. Canaccord Genuity Group restated a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a research report on Thursday, November 7th. Finally, Jefferies Financial Group began coverage on Core Scientific in a research report on Monday, October 28th. They set a “buy” rating and a $19.00 price objective for the company. Thirteen investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $18.46.

Core Scientific Price Performance

Shares of NASDAQ:CORZ opened at $14.04 on Thursday. The firm has a market capitalization of $3.92 billion and a price-to-earnings ratio of -2.60. The business’s 50 day simple moving average is $15.66 and its 200-day simple moving average is $12.61. Core Scientific has a 12 month low of $2.61 and a 12 month high of $18.63.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, CEO Adam Taylor Sullivan sold 88,380 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total value of $1,258,531.20. Following the completion of the sale, the chief executive officer now directly owns 4,128,505 shares of the company’s stock, valued at approximately $58,789,911.20. This represents a 2.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Todd M. Duchene sold 129,861 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total value of $1,849,220.64. Following the sale, the insider now directly owns 2,051,649 shares in the company, valued at $29,215,481.76. This trade represents a 5.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 348,241 shares of company stock worth $5,436,802. 32.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Core Scientific

Several institutional investors and hedge funds have recently bought and sold shares of CORZ. ORG Wealth Partners LLC increased its stake in shares of Core Scientific by 0.3% in the fourth quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock worth $126,262,000 after acquiring an additional 26,649 shares during the last quarter. Parsifal Capital Management LP grew its stake in Core Scientific by 3.9% in the third quarter. Parsifal Capital Management LP now owns 5,412,825 shares of the company’s stock valued at $64,196,000 after purchasing an additional 204,314 shares in the last quarter. Geode Capital Management LLC increased its position in Core Scientific by 26.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,276,573 shares of the company’s stock worth $62,594,000 after purchasing an additional 1,113,285 shares during the last quarter. State Street Corp raised its stake in shares of Core Scientific by 17.0% during the 3rd quarter. State Street Corp now owns 4,006,922 shares of the company’s stock worth $47,522,000 after purchasing an additional 583,493 shares in the last quarter. Finally, Taconic Capital Advisors LP lifted its holdings in shares of Core Scientific by 178.7% during the 3rd quarter. Taconic Capital Advisors LP now owns 2,717,462 shares of the company’s stock valued at $32,229,000 after buying an additional 1,742,462 shares during the last quarter.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.